Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Tofacitinib, a hair regrowth treatment, may worsen acne.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

The protein FLCN is involved in cellular cleanup and is regulated by ULK1.

Researchers found a new gene variant linked to a rare bone disease, which doesn't always cause symptoms in carriers.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

ITK inhibitors may effectively treat alopecia areata.

Different STUB1 gene mutations cause varied symptoms in autosomal recessive ataxias.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

H+-ATPase is crucial for plant growth and can be influenced by microbial compounds, affecting root hair development.

Mutants of CYP154C2 enzyme significantly improved steroid conversion efficiency.

Androgen receptors help prostate cancer cells grow and resist drugs.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tofacitinib is an effective and safe treatment for alopecia areata.

The fer-ts mutation in plants prevents root hair growth at high temperatures.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Higher FABP4 levels may indicate more severe alopecia areata.

All-trans retinoic acid slows cell growth and increases cell death in goat hair follicles through a specific pathway.

Bendamustine combined with tucidinostat may effectively treat adult T-cell leukemia.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

The gene Ascl4 is not necessary for the development of hair, teeth, or mammary glands.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

SSAT is a key enzyme affecting cell growth and metabolism, with potential but risky use in disease treatment.

Abatacept may help some people with alopecia areata regrow hair.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib treatment for hair loss may worsen acne.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.